Anti-TRAIL 抗体 (ab9959)
Key features and details
- Rabbit polyclonal to TRAIL
- Suitable for: Sandwich ELISA
- Reacts with: Recombinant fragment
- Isotype: IgG
製品の概要
-
製品名
Anti-TRAIL antibody
TRAIL 一次抗体 製品一覧 -
製品の詳細
Rabbit polyclonal to TRAIL -
由来種
Rabbit -
アプリケーション
適用あり: Sandwich ELISAmore details -
種交差性
交差種: Recombinant fragment
交差が予測される動物種: Human
-
免疫原
Recombinant fragment corresponding to Human TRAIL aa 100 to the C-terminus. Highly pure (>98%). E.coli derived
Database link: P50591 -
特記事項
Although some customers have been successful in IHC we no longer batch test in this application.
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
製品の特性
-
製品の状態
Lyophilized:Reconstitute with 200µl of sterile water. -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. -
Concentration information loading... -
精製度
Immunogen affinity purified -
ポリ/モノ
ポリクローナル -
アイソタイプ
IgG -
研究分野
関連製品
-
Compatible Secondaries
-
Isotype control
-
Positive Controls
-
Recombinant Protein
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab9959の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
| アプリケーション | Abreviews | 特記事項 |
|---|---|---|
| Sandwich ELISA |
Use a concentration of 0.1 µg/ml.
To detect TRAIL by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with ab12124 as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant TRAIL. |
| 特記事項 |
|---|
|
Sandwich ELISA
Use a concentration of 0.1 µg/ml. To detect TRAIL by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with ab12124 as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant TRAIL. |
ターゲット情報
-
機能
Cytokine that binds to TNFRSF10A/TRAILR1, TNFRSF10B/TRAILR2, TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4 and possibly also to TNFRSF11B/OPG. Induces apoptosis. Its activity may be modulated by binding to the decoy receptors TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4 and TNFRSF11B/OPG that cannot induce apoptosis. -
組織特異性
Widespread; most predominant in spleen, lung and prostate. -
配列類似性
Belongs to the tumor necrosis factor family. -
細胞内局在
Membrane. - Information by UniProt
-
参照データベース
- Entrez Gene: 8743 Human
- Omim: 603598 Human
- SwissProt: P50591 Human
- Unigene: 478275 Human
-
別名
- Apo 2 ligand antibody
- APO 2L antibody
- Apo-2 ligand antibody
see all
画像
データシートおよび資料
-
Datasheet download
参考文献 (14)
ab9959 は 14 報の論文で使用されています。
- Del Rosario H et al. Structure-activity relationships reveal a 2-furoyloxychalcone as a potent cytotoxic and apoptosis inducer for human U-937 and HL-60 leukaemia cells. Bioorg Chem 127:105926 (2022). PubMed: 35717804
- Winterberg D et al. Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo. J Clin Med 10:N/A (2021). PubMed: 34203833
- Rodríguez I et al. Apoptosis Pathways Triggered by a Potent Antiproliferative Hybrid Chalcone on Human Melanoma Cells. Int J Mol Sci 22:N/A (2021). PubMed: 34948260
- Chen J et al. Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer. Signal Transduct Target Ther 6:4 (2021). PubMed: 33414378
- Kitamura Y et al. Anti-EGFR VHH-armed death receptor ligand-engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers. Sci Adv 7:N/A (2021). PubMed: 33658202
